CIS: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in CIS

The CIS medicaments containing corticosteroid hormones market surged to $X in 2021, rising by 57% against the previous year. The total consumption indicated a buoyant increase from 2012 to 2021: its value increased at an average annual rate of +6.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, consumption reached the peak level and is likely to continue growth in the immediate term.

Production of Medicaments Containing Corticosteroid Hormones in CIS

In value terms, medicaments containing corticosteroid hormones production surged to $X in 2021 estimated in export price. Over the period under review, production, however, recorded a noticeable reduction. The most prominent rate of growth was recorded in 2017 with an increase of 48%. As a result, production attained the peak level of $X. From 2018 to 2021, production growth failed to regain momentum.

Exports of Medicaments Containing Corticosteroid Hormones

Exports in CIS

In 2021, after four years of growth, there was significant decline in shipments abroad of medicaments containing corticosteroid hormones, when their volume decreased by -5.8% to X tons. Total exports indicated prominent growth from 2012 to 2021: its volume increased at an average annual rate of +9.8% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +53.0% against 2016 indices. The pace of growth was the most pronounced in 2013 with an increase of 43% against the previous year. Over the period under review, the exports reached the peak figure at X tons in 2020, and then dropped in the following year.

In value terms, medicaments containing corticosteroid hormones exports expanded significantly to $X in 2021. The total export value increased at an average annual rate of +2.6% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The growth pace was the most rapid in 2018 when exports increased by 20% against the previous year. The level of export peaked in 2021 and is likely to see steady growth in years to come.

Exports by Country

Russia (X tons) and Belarus (X tons) dominates exports structure, together committing 92% of total exports. It was distantly followed by Moldova (X tons), constituting a 5.8% share of total exports.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the leading exporting countries, was attained by Moldova (with a CAGR of +41.6%), while the other leaders experienced more modest paces of growth.

In value terms, Russia ($X) remains the largest medicaments containing corticosteroid hormones supplier in the CIS, comprising 57% of total exports. The second position in the ranking was taken by Belarus ($X), with a 22% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of value in Russia stood at -2.0%. The remaining exporting countries recorded the following average annual rates of exports growth: Belarus (+25.2% per year) and Moldova (+37.4% per year).

Export Prices by Country

In 2021, the export price in the CIS amounted to $X per ton, picking up by 19% against the previous year. In general, the export price, however, continues to indicate a abrupt slump. The level of export peaked at $X per ton in 2012; however, from 2013 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was Moldova ($X per ton), while Belarus ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Belarus (+2.5%), while the other leaders experienced a decline in the export price figures.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in CIS

In 2021, approx. X tons of medicaments containing corticosteroid hormones were imported in the CIS; picking up by 23% compared with 2020. Total imports indicated a resilient expansion from 2012 to 2021: its volume increased at an average annual rate of +7.3% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports decreased by -2.9% against 2019 indices. The pace of growth appeared the most rapid in 2019 when imports increased by 42%. As a result, imports reached the peak of X tons. From 2020 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing corticosteroid hormones imports skyrocketed to $X in 2021. Total imports indicated a tangible expansion from 2012 to 2021: its value increased at an average annual rate of +3.4% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports decreased by -10.6% against 2019 indices. The growth pace was the most rapid in 2019 with an increase of 54%. As a result, imports reached the peak of $X. From 2020 to 2021, the growth of imports failed to regain momentum.

Imports by Country

Russia prevails in imports structure, reaching X tons, which was approx. 81% of total imports in 2021. It was distantly followed by Kazakhstan (X tons), mixing up a 7.5% share of total imports. The following importers - Azerbaijan (X tons) and Belarus (X tons) - each resulted at a 6.1% share of total imports.

From 2012 to 2021, average annual rates of growth with regard to medicaments containing corticosteroid hormones imports into Russia stood at +7.2%. At the same time, Azerbaijan (+25.3%), Kazakhstan (+5.4%) and Belarus (+3.8%) displayed positive paces of growth. Moreover, Azerbaijan emerged as the fastest-growing importer imported in the CIS, with a CAGR of +25.3% from 2012-2021. From 2012 to 2021, the share of Azerbaijan increased by +2.3 percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Russia ($X) constitutes the largest market for imported medicaments containing corticosteroid hormones in the CIS, comprising 79% of total imports. The second position in the ranking was taken by Kazakhstan ($X), with a 7.9% share of total imports. It was followed by Belarus, with a 4.6% share.

From 2012 to 2021, the average annual rate of growth in terms of value in Russia amounted to +2.1%. In the other countries, the average annual rates were as follows: Kazakhstan (+8.3% per year) and Belarus (+4.7% per year).

Import Prices by Country

The import price in the CIS stood at $X per ton in 2021, picking up by 11% against the previous year. Over the period under review, the import price, however, saw a perceptible decline. The growth pace was the most rapid in 2013 when the import price increased by 15%. As a result, import price attained the peak level of $X per ton. From 2014 to 2021, the import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was Belarus ($X per ton), while Azerbaijan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Azerbaijan (+15.2%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :